ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000267198.1	Tanespimycin	Chronic Lymphocytic Leukemia	0.041691853	Resistant
ENSG00000267198.1	Tanespimycin	Skin cutaneous melanoma	0.041017212	Resistant